KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 112 filers reported holding KEROS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,393 | -49.3% | 43,700 | -36.1% | 0.00% | -50.0% |
| Q2 2023 | $2,748 | -46.9% | 68,400 | -43.5% | 0.00% | -42.9% |
| Q1 2023 | $5,171 | +17.2% | 121,100 | +31.8% | 0.01% | +16.7% |
| Q4 2022 | $4,413 | -99.9% | 91,900 | -5.5% | 0.01% | +20.0% |
| Q3 2022 | $3,657,000 | -6.6% | 97,200 | -31.4% | 0.01% | 0.0% |
| Q2 2022 | $3,915,000 | +1259.4% | 141,700 | +2573.6% | 0.01% | – |
| Q1 2022 | $288,000 | -70.4% | 5,300 | -78.4% | 0.00% | -100.0% |
| Q3 2021 | $972,000 | +36.5% | 24,572 | +143.3% | 0.00% | 0.0% |
| Q4 2020 | $712,000 | +4.2% | 10,100 | -42.9% | 0.00% | 0.0% |
| Q3 2020 | $683,000 | +189.4% | 17,700 | +181.0% | 0.00% | – |
| Q2 2020 | $236,000 | – | 6,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 396,911 | $21,584,000 | 5.10% |
| Deep Track Capital, LP | 1,380,306 | $75,061,000 | 4.81% |
| Opaleye Management Inc. | 265,750 | $14,451,000 | 4.49% |
| Octagon Capital Advisors LP | 340,214 | $18,501,000 | 4.00% |
| First Light Asset Management, LLC | 658,145 | $35,790,000 | 3.16% |
| Altium Capital Management LP | 126,000 | $6,852,000 | 2.29% |
| Nantahala Capital Management | 816,830 | $44,419,000 | 1.96% |
| Orbimed Advisors | 1,679,417 | $91,327,000 | 1.48% |
| CHI Advisors LLC | 62,229 | $3,384,000 | 1.44% |
| Parkman Healthcare Partners LLC | 72,690 | $3,953,000 | 1.16% |